Holen Sie sich die Stockscreener-App
33.31
2.37%
-0.81
Handel nachbörslich:
32.78
-0.53
-1.59%
Schlusskurs vom Vortag:
$34.12
Offen:
$34.68
24-Stunden-Volumen:
270.27K
Relative Volume:
0.68
Marktkapitalisierung:
$625.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.30M
KGV:
-8.651
EPS:
-3.8504
Netto-Cashflow:
$-62.65M
1W Leistung:
-7.14%
1M Leistung:
+49.51%
6M Leistung:
+87.98%
1J Leistung:
+41.68%
1-Tages-Spanne:
$31.39
$34.68
1-Wochen-Bereich:
$31.39
$35.80
52-Wochen-Spanne:
$13.70
$36.03
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
33.31 | 640.66M | 0 | -67.30M | -62.65M | -3.8504 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-21 | Eingeleitet | Mizuho | Outperform |
| 2024-11-20 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | TD Cowen | Buy |
| 2023-12-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-05 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Buy |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-03-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-16 | Eingeleitet | Wedbush | Outperform |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Gains Report: Can Tectonic Therapeutic Inc outperform under higher oil prices2026 Gainers & Long-Term Capital Growth Strategies - baoquankhu1.vn
Tectonic Therapeutic (TECX) to Release Earnings on Thursday - MarketBeat
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Insider Sell: Marcella Ruddy Sells Shares of Tectonic Therapeuti - GuruFocus
Peter Mcnamara Sells 6,262 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 10,000 Shares of Stock - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 9.8%Should You Sell? - MarketBeat
Stocks showing market leadership: Tectonic Therapeutic earns 96 RS rating - MSN
Published on: 2026-03-08 21:54:41 - baoquankhu1.vn
Aug Breakouts: Can Tectonic Therapeutic Inc. lead its sector in growthMarket Activity Recap & Community Driven Trade Alerts - baoquankhu1.vn
Published on: 2026-03-07 08:33:07 - baoquankhu1.vn
Unveiling Bumps: How Tectonic Therapeutic’s Recent Moves Affect the Market - timothysykes.com
Peter Mcnamara Sells 1,650 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 1,649 Shares of Stock - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month HighHere's Why - MarketBeat
TECX (TECX) Rule 144 notice: 1,650 RSUs proposed; 1,649 sold under 10b5-1 - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 11.4%What's Next? - MarketBeat
[144] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan
Tectonic Therapeutic to Participate in March Investor Conferences - Bitget
Quarterly Risk: Is Tectonic Therapeutic Inc stock forming a cup and handleJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - baoquankhu1.vn
TECX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Promising Biotech with a Potential 227% Upside - DirectorsTalk Interviews
Chen Yu and TCG report 6.2% stake in Tectonic Therapeutic (NASDAQ: TECX) - Stock Titan
Tectonic Therapeutics' Q4 Net Loss Widens; Phase 2 APEX Trial Data Due In 2026 - Nasdaq
TECX Should I Buy - Intellectia AI
TECX: Strong cash position and advancing clinical pipeline, with key trial results expected in 2026 - TradingView
Tectonic Therapeutic, Inc. Reports Positive Phase 1b Results for TX45 in Pulmonary Hypertension and Advances TX2100 into Phase 1a Trial for Hereditary Hemorrhagic Telangiectasia - Quiver Quantitative
TECXForm 8-KCurrent report - ADVFN Ltd
Tectonic Therapeutic, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic drug cuts heart-lung pressure 29%, backed by cash into 2028 - Stock Titan
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX) - Seeking Alpha
Tectonic Therapeutic, Inc.Common Stock (NQ: TECX - The Chronicle-Journal
Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins - MarketBeat
Tectonic Therapeutic Announces Leadership Transition and New Chair - TipRanks
Insider Trends: Is now the right time to enter Tectonic Therapeutic IncDollar Strength & Daily Entry Point Alerts - baoquankhu1.vn
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board - citybiz
Tectonic Therapeutic appoints François Nader as chair and independent director of the board - marketscreener.com
Tectonic Therapeutic Appoints François Nader As Chair And Independent Director Of The Board - TradingView
Tectonic Therapeutic Appoints Francois Nader, M.D., as Chair and Independent Director of the Board - Bitget
Can Tectonic Therapeutic Inc. lead its sector in growthDividend Hike & Entry Point Confirmation Alerts - mfd.ru
Aberdeen Group plc Takes $5.59 Million Position in Tectonic Therapeutic, Inc. $TECX - MarketBeat
What are Tectonic Therapeutic Inc.’s technical support levels2025 Winners & Losers & Community Consensus Trade Signals - mfd.ru
Is Tectonic Therapeutic Inc. stock a smart retirement pickJuly 2025 Gainers & Free Community Consensus Stock Picks - mfd.ru
Market Outlook: Will KINS stock hit new highs in YEAREarnings Risk Report & Capital Protection Trading Alerts - baoquankhu1.vn
MSN Money - MSN
Published on: 2026-02-16 17:45:36 - baoquankhu1.vn
Can Tectonic Therapeutic Inc. stock double in the next yearLayoff News & Real-Time Stock Entry Alerts - mfd.ru
Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic - Yahoo Finance
Is Tectonic Therapeutic Inc. subject to activist investor interest2025 Biggest Moves & Entry Point Confirmation Signals - mfd.ru
Will Tectonic Therapeutic Inc. benefit from rate cutsJuly 2025 Summary & High Accuracy Investment Entry Signals - mfd.ru
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):